R. Lurvink

发表

Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up.

M. Simone, A. Nissan, M. Pocard, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study

V. Lemmens, I. de Hingh, C. Verhoef, 2021, Annals of Surgical Oncology.

The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI).

B. Rau, D. Morris, P. Piso, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort

R. Verhoeven, J. V. van Sandick, I. de Hingh, 2021, Gastric Cancer.

Identification of pharmacogenetic biomarkers for efficacy of cytoreductive surgery plus hyperthermic intraperitoneal mitomycin C in patients with colorectal peritoneal metastases.

S. Böhringer, T. van Wezel, H. Gelderblom, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC)

M. Lahaye, J. Burger, I. de Hingh, 2019, BMJ Open.

Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment.

M. Simone, A. Nissan, B. Rau, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study

J. Tuynman, V. Lemmens, I. de Hingh, 2022, Surgical Endoscopy.

Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid

G. Meijer, C. Punt, M. Lahaye, 2021, The journal of pathology. Clinical research.

The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival

J. V. van Sandick, G. Nieuwenhuijzen, I. de Hingh, 2021, Journal of clinical medicine.

Synchronous peritoneal metastases from lung cancer: incidence, associated factors, treatment and survival: a Dutch population-based study

I. de Hingh, M. Aarts, F. V. van Erning, 2021, Clinical & Experimental Metastasis.

Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC)

J. Burger, F. Mols, I. de Hingh, 2021, Surgical Endoscopy.

First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II)

J. Burger, I. de Hingh, M. Los, 2021, BMJ Open.

Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC)

M. Lahaye, J. Burger, I. de Hingh, 2021, Annals of Surgical Oncology.

The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma.

M. Simone, A. Nissan, J. Burger, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Incidence, risk factors, treatment, and survival of ovarian metastases of colorectal origin: a Dutch population-based study

V. Lemmens, R. Meer, R. Roumen, 2020, International Journal of Colorectal Disease.

Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial

J. Burger, M. Deenen, D. Boerma, 2020, Annals of Surgical Oncology.

The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review.

I. D. de Hingh, K. van der Speeten, K. Rovers, 2021, Journal of gastrointestinal oncology.

Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic review.

J. Burger, I. de Hingh, G. Creemers, 2020, Journal of gastrointestinal oncology.

ASO Author Reflections: PIPAC for Unresectable Colorectal Peritoneal Metastases

I. de Hingh, S. Nienhuijs, K. Rovers, 2021, Annals of Surgical Oncology.

Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.

J. Burger, I. de Hingh, C. Verhoef, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

ASO Author Reflections: Treatment and Prognosis of Colorectal Peritoneal Metastases

I. de Hingh, S. Nienhuijs, F. V. van Erning, 2021, Annals of Surgical Oncology.

RE: Phase I dose escalation study of oxaliplatin delivered via a laparoscopic approach using pressurized intraperitoneal aerosol chemotherapy (PIPAC) for advanced peritoneal metastases of gastrointestinal tract cancers: PIPAC-oxaliplatin for peritoneal metastases of gastrointestinal cancers.

I. de Hingh, M. Deenen, K. Rovers, 2021, European journal of cancer.

The Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) versus Conventional Surgery on Patient-Reported Outcomes: A Comparative Cohort Study between the CAIRO6 Trial and the PROCORE Study

J. Burger, F. Mols, C. Bonhof, 2023, Cancers.

Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial

A. Aalbers, J. Burger, S. Kruijff, 2023, Annals of Surgical Oncology.

ASO Author Reflection: Systemic Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy with Oxaliplatin in Patients with Colorectal Peritoneal Metastases

M. Deenen, I. Hingh, K. Rovers, 2020, Annals of Surgical Oncology.

Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases.

J. Burger, R. Mathijssen, G. Creemers, 2023, The British journal of surgery.

Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial

J. Burger, E. van Meerten, S. Nienhuijs, 2024, BMJ Open.